From Genomic Risk to Precision Prevention: Transforming Women's Cancer Care

Thursday, January 28, 2027 at 2:10 PM to 2:40 PM · 30 min. (Europe/London)
Pharmacogenomics & Patient Stratification Stage
Day 2 - Thursday 28th January
CancerPolygenic Risk ScoresPrecision Medicine

Information

  • Using population genomic testing to identify individuals at increased risk of women's cancers.  
  • Translating personalised risk assessment into targeted screening, surveillance and prevention.  
  • Insights from ongoing genomic clinical trials in precision prevention.  
  • The role of health economics and evidence generation in shaping national guidelines.  
  • Scaling personalised prevention through digital tools and population-level implementation.